Moreover, PFKFB3 has been shown to act as a therapeutic target and participate in a variety of regulatory mechanisms in various diseases, such as cancer [54–57], pulmonary hypertension [58, 59], pulmonary fibrosis [60–62], and atherosclerosis [63, 64]. This evidence concerns the gene PFKFB3 and pulmonary arterial hypertension.